External Validation of Multiple Predictive Models in AIS Patients Undergoing Intravenous Thrombolysis

Background and Purpose-ASPECTS (Alberta Stroke Program Early CT Score), ASTRAL (Acute Stroke Registry and Analysis of LausanneL), DRAGON (including intensive middle cerebral artery sign, pre-stroke modified Rankin Scale score, age, glucose, onset to treatment, NIH Stroke Scale score), THRIVE-c (Total Health Risks in Vascular Events- calculation score) and START (NIHSS Stroke Scale score, Age, pre-stroke mRS score, onset-to-treatment Time) are predictive models that have been gradually developed in recent years to predict functional outcome after acute stroke in patients treated with intravenous thrombolysis, respectively. We aimed to externally validate these scores to assess their predictive performance in this advanced stroke center in China. Methods- We examined the clinical data of 835 patients with AIS who were admitted to the emergency department for intravenous thrombolysis at the Advanced Stroke Center, First Central Hospital, Baoding, China, between January 2016 and May 2022, and scored the patients using the ASPECTS, ASTRAL, DRAGON, THRIVE-c, and START scales. The 3-month modified Rankin Scale scores were observed for each score point, and patients with scores 3 to 6 were defined as having a poor prognosis and compared with the proportions predicted based on risk scores. The ROC curve was used to analyze the predictive value of each score for poor prognosis at 3 months. The total area under the ROC curve showed that it was the C value, and the C value was compared with the predictive value of the five scores; The Hosmer-Lemeshow (H-L) goodness-of-fit [χ2 (P)] test was applied to evaluate the fit of each model to the actual results; two indicators, the calibration curve and the Brier score, were used to evaluate the calibration of the models. Multivariate logistic regression coefficients for the variables in the five scores were also compared with the original derivation cohort. Results-Finally, 728 patients were included, and 318 (43.68%) had a poor prognosis. roc curve analysis, ASPECTS, ASTRAL, DRAGON, THRIVE-c, and START scores corresponded to C values of 0.851, 0.825, 0.854, 0.809, and 0819 in the overall patients, respectively, and in the pre-circulation 0.853, 0.813, 0.833, 0.804, 0.807, and 0.848, 0.862, 0.909, 0.811, 0.857 in the posterior cycle, respectively (all P > 0.05).Hosmer-Lemeshow goodness-of-fit tests for ASPECTS, ASTRAL, DRAGON, THRIVE-c, and START scores with P values of P P P P P P P P P P P